Morgan Stanley Regeneron Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,339,499 shares of REGN stock, worth $1.31 Billion. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,339,499

Previous 1,139,519 17.55%

Holding current value

$1.31 Billion

Previous $1 Billion 28.82%

% of portfolio

0.1%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $181 Million - $199 Million	199,980 Added 17.55%	1,339,499 $1.29 Billion
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $131 Million - $149 Million	168,562 Added 17.36%	1,139,519 $1 Billion
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $17.9 Million - $21.8 Million	25,792 Added 2.73%	970,957 $799 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $23 Million - $27.3 Million	32,889 Added 3.61%	945,165 $679 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $15.6 Million - $18.9 Million	22,898 Added 2.57%	912,276 $750 Million

Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $62.9 Million - $68.3 Million	89,081 Added 11.13%	889,378 $642 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $24.3 Million - $30.6 Million	42,253 Added 5.57%	800,297 $551 Million
Q2 2022 Oct 27, 2022	BUY	$548.35 - $738.84 $164 Million - $221 Million	299,537 Added 65.33%	758,044 $448 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $164 Million - $221 Million	299,537 Added 65.33%	758,044 $448 Million
Q1 2022 Oct 27, 2022	SELL	$595.12 - $698.43 $178 Million - $209 Million	-299,537 Reduced 39.51%	458,507 $320 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $46.1 Million - $54.1 Million	-77,525 Reduced 14.46%	458,507 $320 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $22.5 Million - $27.7 Million	41,339 Added 8.36%	536,032 $339 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $284 Million - $337 Million	494,693 New	494,693 $299 Million

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $105B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account